| Market Capitalization (Millions $) |
- |
| Shares
Outstanding (Millions) |
101 |
| Employees |
- |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
-43 |
| Cash Flow (TTM) (Millions $) |
-20 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Allena Pharmaceuticals Inc. is a biopharmaceutical company that focuses on developing and commercializing innovative solutions for patients suffering from rare and severe metabolic disorders. The company is dedicated to transforming the treatment landscape by targeting underlying metabolic pathways to address unmet needs.
Allena Pharmaceuticals leverages its deep expertise in using enzymes to modulate metabolism, with a focus on designing and developing oral enzyme therapeutics. By targeting specific metabolic pathways, the company aims to develop novel, non-absorbed oral therapeutics that can be administered conveniently and effectively.
The company's pipeline of drug candidates includes potential treatments for hyperoxaluria, a disorder characterized by the overproduction of oxalate, as well as other rare and severe metabolic disorders. Allena Pharmaceuticals is committed to advancing its drug candidates through clinical development stages to ultimately provide patients with effective and safe treatment options.
In summary, Allena Pharmaceuticals Inc. is a biopharmaceutical company dedicated to developing and commercializing innovative therapies for rare and severe metabolic disorders through targeting specific metabolic pathways.
Company Address: 142-F North Road Sudbury 1776 MA
Company Phone Number: 467-4577 Stock Exchange / Ticker: NASDAQ ALNA
|
%